174.90
price up icon1.39%   2.40
after-market アフターアワーズ: 174.90
loading
前日終値:
$172.50
開ける:
$173.77
24時間の取引高:
915.70K
Relative Volume:
0.97
時価総額:
$8.61B
収益:
$4.02B
当期純損益:
$-142.16M
株価収益率:
-59.16
EPS:
-2.9563
ネットキャッシュフロー:
$518.49M
1週間 パフォーマンス:
+5.43%
1か月 パフォーマンス:
-2.01%
6か月 パフォーマンス:
+2.59%
1年 パフォーマンス:
+19.80%
1日の値動き範囲:
Value
$171.66
$176.20
1週間の範囲:
Value
$153.25
$176.20
52週間の値動き範囲:
Value
$91.86
$228.88

Charles River Laboratories International Inc Stock (CRL) Company Profile

Name
名前
Charles River Laboratories International Inc
Name
セクター
Healthcare (1116)
Name
電話
781-222-6000
Name
住所
251 BALLARDVALE ST, WILMINGTON, MA
Name
職員
19,700
Name
Twitter
@criverlabs
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
CRL's Discussions on Twitter

Compare CRL vs TMO, DHR, IDXX, A, WAT

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
CRL icon
CRL
Charles River Laboratories International Inc
174.90 8.49B 4.02B -142.16M 518.49M -2.9563
TMO icon
TMO
Thermo Fisher Scientific Inc
494.54 182.60B 44.56B 6.72B 6.29B 17.74
DHR icon
DHR
Danaher Corp
190.79 134.18B 24.57B 3.60B 5.26B 5.051
IDXX icon
IDXX
Idexx Laboratories Inc
564.66 44.63B 4.30B 1.06B 1.04B 13.08
A icon
A
Agilent Technologies Inc
114.54 32.21B 7.07B 1.29B 993.00M 4.5355
WAT icon
WAT
Waters Corp
299.89 29.21B 3.17B 642.63M 516.49M 10.77

Charles River Laboratories International Inc Stock (CRL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-12-15 アップグレード BofA Securities Neutral → Buy
2025-11-17 アップグレード Argus Hold → Buy
2025-11-06 アップグレード Robert W. Baird Neutral → Outperform
2025-10-06 アップグレード William Blair Mkt Perform → Outperform
2025-10-02 アップグレード Barclays Equal Weight → Overweight
2025-09-09 アップグレード Jefferies Hold → Buy
2025-07-09 アップグレード Citigroup Neutral → Buy
2025-05-23 アップグレード Redburn Atlantic Neutral → Buy
2025-05-14 アップグレード TD Cowen Hold → Buy
2025-05-08 アップグレード Evercore ISI In-line → Outperform
2025-03-21 ダウングレード Goldman Buy → Neutral
2025-03-04 アップグレード Citigroup Sell → Neutral
2025-03-03 アップグレード Redburn Atlantic Sell → Neutral
2025-01-22 ダウングレード William Blair Outperform → Mkt Perform
2025-01-17 ダウングレード UBS Buy → Neutral
2024-11-18 ダウングレード CLSA Hold → Underperform
2024-11-07 アップグレード CLSA Underperform → Hold
2024-10-23 開始されました CLSA Underperform
2024-10-14 開始されました Redburn Atlantic Sell
2024-10-07 ダウングレード Evercore ISI Outperform → In-line
2024-10-02 ダウングレード BofA Securities Buy → Neutral
2024-10-01 ダウングレード Citigroup Neutral → Sell
2024-08-08 ダウングレード JP Morgan Overweight → Neutral
2024-08-08 ダウングレード Robert W. Baird Outperform → Neutral
2024-06-28 ダウングレード Argus Buy → Hold
2024-06-07 開始されました Mizuho Neutral
2024-06-06 開始されました Goldman Buy
2024-02-15 ダウングレード Guggenheim Buy → Neutral
2023-09-13 開始されました TD Cowen Market Perform
2023-07-10 ダウングレード Citigroup Buy → Neutral
2023-02-23 アップグレード Guggenheim Neutral → Buy
2023-01-12 ダウングレード Jefferies Buy → Hold
2022-09-30 アップグレード Jefferies Hold → Buy
2022-08-25 開始されました Credit Suisse Outperform
2022-08-04 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-05-24 開始されました Guggenheim Neutral
2022-04-25 ダウングレード Jefferies Buy → Hold
2022-04-07 開始されました Stephens Overweight
2022-02-17 繰り返されました BofA Securities Buy
2022-02-17 アップグレード Citigroup Neutral → Buy
2022-02-17 繰り返されました Deutsche Bank Buy
2022-02-17 繰り返されました Morgan Stanley Overweight
2022-02-17 繰り返されました UBS Buy
2021-08-05 再開されました Credit Suisse Neutral
2020-12-16 ダウングレード Citigroup Buy → Neutral
2020-09-10 アップグレード Jefferies Hold → Buy
2020-07-01 アップグレード BofA Securities Neutral → Buy
2020-05-13 アップグレード UBS Neutral → Buy
2020-04-21 ダウングレード Jefferies Buy → Hold
2020-03-27 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-03-02 開始されました Deutsche Bank Buy
2020-02-18 アップグレード Wolfe Research Peer Perform → Outperform
2020-01-10 アップグレード Goldman Neutral → Buy
2020-01-08 開始されました Wells Fargo Overweight
2020-01-07 開始されました Citigroup Buy
2019-10-18 ダウングレード BofA/Merrill Buy → Neutral
2019-06-10 開始されました SVB Leerink Outperform
2019-04-30 再開されました Evercore ISI Outperform
2018-12-14 開始されました Deutsche Bank Buy
2018-10-09 開始されました UBS Neutral
2018-08-23 アップグレード Raymond James Mkt Perform → Outperform
2018-07-17 アップグレード RBC Capital Mkts Sector Perform → Outperform
2018-06-15 アップグレード KeyBanc Capital Mkts Sector Weight → Overweight
2018-02-14 アップグレード SunTrust Hold → Buy
すべてを表示

Charles River Laboratories International Inc (CRL) 最新ニュース

pulisher
Apr 01, 2026

Charles River Laboratories International Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch

Apr 01, 2026
pulisher
Apr 01, 2026

CRL Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 01, 2026
pulisher
Mar 31, 2026

Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MSN

Mar 31, 2026
pulisher
Mar 31, 2026

AI-led selloff in contract research firms may be misjudging disruption risk - Reuters

Mar 31, 2026
pulisher
Mar 31, 2026

[ARS] CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SEC Filing - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

Charles River (NYSE: CRL) details CEO transition, 4.8M-share incentive plan in 2026 proxy - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

Allspring Global Investments Holdings LLC Cuts Stock Holdings in Charles River Laboratories International, Inc. $CRL - MarketBeat

Mar 31, 2026
pulisher
Mar 31, 2026

Charles River Laboratories Stock: A Key Player in Drug Discovery Services for North American Investo - AD HOC NEWS

Mar 31, 2026
pulisher
Mar 30, 2026

Valuation Update: Will Charles River Laboratories International Inc benefit from green energy policies2026 Volatility Report & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 30, 2026

Charles River Laboratories International Inc (CRL) Shares Down 3 - GuruFocus

Mar 30, 2026
pulisher
Mar 29, 2026

Why is Charles River (CRL) down 6.8% since last earnings report? - MSN

Mar 29, 2026
pulisher
Mar 29, 2026

A Look At Charles River Laboratories (CRL) Valuation After Recent Share Price Weakness - Yahoo Finance

Mar 29, 2026
pulisher
Mar 28, 2026

Charles River Laboratories stock: Is CRL underperforming the healthcare sector? - MSN

Mar 28, 2026
pulisher
Mar 28, 2026

Assenagon Asset Management S.A. Increases Stake in Charles River Laboratories International, Inc. $CRL - MarketBeat

Mar 28, 2026
pulisher
Mar 27, 2026

Charles River Laboratories International Inc. stock underperforms Friday when compared to competitors - MarketWatch

Mar 27, 2026
pulisher
Mar 27, 2026

FinancialContentRadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know - FinancialContent

Mar 27, 2026
pulisher
Mar 27, 2026

Charles River Laboratories International Inc (CRL) Shares Gap Do - GuruFocus

Mar 27, 2026
pulisher
Mar 27, 2026

Riverbridge Partners LLC Reduces Stock Position in Charles River Laboratories International, Inc. $CRL - MarketBeat

Mar 27, 2026
pulisher
Mar 27, 2026

Top Charles River Laboratories International (CRL) Competitors 2026 - MarketBeat

Mar 27, 2026
pulisher
Mar 26, 2026

Charles River Laboratories Experiences Evaluation Revision Amid Mixed Market Signals - Markets Mojo

Mar 26, 2026
pulisher
Mar 26, 2026

Vanguard realigns holdings; Charles River (NYSE: CRL) shows 0% stake - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

Volume Report: Will Charles River Laboratories International Inc benefit from green energy policies2026 Recap & Smart Investment Allocation Insights - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 26, 2026

U.S. Sterility Testing Market Set to Boom Rapidly by 2033 | Thermo - openPR.com

Mar 26, 2026
pulisher
Mar 26, 2026

Charles River extends gains as Evercore upgrades after Q1 beat - msn.com

Mar 26, 2026
pulisher
Mar 26, 2026

SG Americas Securities LLC Invests $36.26 Million in Charles River Laboratories International, Inc. $CRL - MarketBeat

Mar 26, 2026
pulisher
Mar 26, 2026

Nordea Investment Management AB Grows Stock Position in Charles River Laboratories International, Inc. $CRL - MarketBeat

Mar 26, 2026
pulisher
Mar 25, 2026

Charles River Labs stock faces technical shift to sideways amid mixed signals and 2026 guidance - AD HOC NEWS

Mar 25, 2026
pulisher
Mar 24, 2026

Contravisory Investment Management Inc. Takes $1.22 Million Position in Charles River Laboratories International, Inc. $CRL - Defense World

Mar 24, 2026
pulisher
Mar 23, 2026

Charles River Laboratories Stock: Is CRL Underperforming the Healthcare Sector? - Yahoo Finance

Mar 23, 2026
pulisher
Mar 23, 2026

Could Charles River (CRL) Using Locus Cell Tie-Up to Reframe Its Asia-Pacific Growth Strategy? - simplywall.st

Mar 23, 2026
pulisher
Mar 23, 2026

Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors - MSN

Mar 23, 2026
pulisher
Mar 22, 2026

10,284 Shares in Charles River Laboratories International, Inc. $CRL Purchased by Oliver Luxxe Assets LLC - MarketBeat

Mar 22, 2026
pulisher
Mar 21, 2026

JPMorgan Chase & Co. Raises Stake in Charles River Laboratories International, Inc. $CRL - MarketBeat

Mar 21, 2026
pulisher
Mar 20, 2026

Why Is Charles River (CRL) Down 6.8% Since Last Earnings Report? - Yahoo Finance

Mar 20, 2026
pulisher
Mar 20, 2026

Confluence Investment Management LLC Has $21.07 Million Position in Charles River Laboratories International, Inc. $CRL - MarketBeat

Mar 20, 2026
pulisher
Mar 18, 2026

FDA issues guidance on alternatives to animal testing - MSN

Mar 18, 2026
pulisher
Mar 17, 2026

Charles River Laboratories International, Inc. (NYSE:CRL) Sees Significant Increase in Short Interest - MarketBeat

Mar 17, 2026
pulisher
Mar 17, 2026

Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

Mar 17, 2026
pulisher
Mar 17, 2026

Charles River Laboratories International (CRL) faces biotech R&D spending headwinds - MSN

Mar 17, 2026
pulisher
Mar 17, 2026

National Bank of Canada FI Grows Stock Position in Charles River Laboratories International, Inc. $CRL - MarketBeat

Mar 17, 2026
pulisher
Mar 16, 2026

Charles River announces divestitures, updates guidance - MSN

Mar 16, 2026
pulisher
Mar 16, 2026

Charles River Laboratories International Inc. stock underperforms Monday when compared to competitors - MarketWatch

Mar 16, 2026
pulisher
Mar 16, 2026

CRL,PBE Volatility & Greeks - Finviz

Mar 16, 2026
pulisher
Mar 16, 2026

Charles River Laboratories International, Inc. $CRL Holdings Reduced by Iron Triangle Partners LP - MarketBeat

Mar 16, 2026

Charles River Laboratories International Inc (CRL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
DGX DGX
$197.69
price up icon 0.87%
LH LH
$272.74
price up icon 2.22%
MTD MTD
$1,274.05
price up icon 1.02%
$203.21
price up icon 1.61%
IQV IQV
$172.40
price up icon 1.09%
WAT WAT
$299.89
price up icon 0.70%
大文字化:     |  ボリューム (24 時間):